Patents by Inventor Max WARNCKE

Max WARNCKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12325870
    Abstract: Provided herein are solubilized apyrase polypeptides, nucleotides encoding such solubilized apyrase polypeptides, pharmaceutical compositions containing such solubilized apyrase polypeptides, therapeutic uses of such solubilized apyrase polypeptides. Also provided herein are methods useful for preventing or treating tissue damage, e.g., by administering a solubilized apyrase polypeptide or pharmaceutical composition thereof, and methods for producing such solubilized apyrase polypeptides.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: June 10, 2025
    Assignee: NOVARTIS AG
    Inventors: Agostino Cirillo, Hilmar Ebersbach, Boerje Haraldsson, Thomas Huber, Guido Junge, Regina Link, Max Warncke, Chao Zou
  • Publication number: 20250179447
    Abstract: The invention relates to design and therapeutic use of solubilized apyrase polypeptides, pharmaceuticals compositions, therapeutic uses and methods useful for preventing and treating tissue damage.
    Type: Application
    Filed: September 26, 2024
    Publication date: June 5, 2025
    Inventors: Agostino CIRILLO, Hilmar EBERSBACH, Boerje HARALDSSON, Thomas HUBER, Guido JUNGE, Regina LINK, Max WARNCKE, Chao ZOU
  • Publication number: 20240309084
    Abstract: The present disclosure features bifunctional compounds for the degradation of extracellular targets, as well as compositions and related methods thereof.
    Type: Application
    Filed: January 18, 2022
    Publication date: September 19, 2024
    Inventors: Martin ALLAN, Jeffrey BAGDANOFF, David Weninger BARNES, John BLANKENSHIP, James BRADNER, Kevin CLAIRMONT, Brian GRANDA, Guido JUNGE, Thomas SMITH, Elisabetta TRAGGIAI, Max WARNCKE
  • Publication number: 20220356455
    Abstract: The invention relates to design and therapeutic use of solubilized apyrase polypeptides, pharmaceuticals compositions, therapeutic uses and methods useful for preventing and treating tissue damage.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 10, 2022
    Inventors: Agostino CIRILLO, Hilmar EBERSBACH, Boerje HARALDSSON, Thomas HUBER, Guido JUNGE, Regina LINK, Max WARNCKE, Chao ZOU